3rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

Upcoming Conference

Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs CONTACT
Biosimilars-2014
Home
Gallery
Biosimilars-2014 Report

Biosimilars-2014 Report

OMICS Group’s 3rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars at Hyderabad International Convention Center, Hyderabad, India during October 27-29, 2014 was organized with a focus on Critical Review on “Current Challenges and Opportunities in Cost Effective and Affordable Biosimilars” was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering.

Biosimilars-2014 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of Biowaivers, Biologics and Biosimilars.

OMICS Group International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Biosimilars-2014:

Nigel Rulewski, Quintiles Inc., USA
Mohan Dewan, R.K. Dewan & Co., India
Steven Lehrer, Cipla Ltd., USA
Heike Schoen, LUMIS International GmbH, Germany
Krishna Menon, Cellceutix Corporation, USA
Rodeina Challand, PRA Health Sciences, UK
Daniel Galbraith, BioOutsource Ltd., UK
Kamali Chance, Quintiles Inc., USA

OMICS Group, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Rodeina Challand, PRA Health Sciences, UK and Dr. Rajiv Dahiya, Association of Pharmacy Professionals, India for their valuable time.

Best Poster Winners:
Anjaneyulu Narapusetti, JNTU-K, India
Rapaka Naga Kishore, JJT University, India
Syeda Sumayya Siraj, Deccan School of Pharmacy, India
Mohammed Nooman, Deccan School of Pharmacy, India
Sufiyan Ahmad, Association of Pharmacy Professionals, India
K Malawika Maheshwari, Doctor of Pharmacy Association, India

OMICS Group also took the privilege of felicitating Biosimilars-2014 Organizing Committee, Keynote Speakers, Chair and Co-Chairs whose support made conference a great success.

With the enormous feedback from the participants and supporters of Biosimilars-2014, OMICS Group Conferences is glad to announce 4th International Conference and Exhibition on Biologics and Biosimilars October 26-28, 2015 Baltimore, USA



Expert Presentations
Krishna Menon

Cellceutix Corporation

USA
Rodeina Challand

PRA Health Sciences

UK
Kamali Chance

Quintiles Inc.

USA
Steven Lehrer

Cipla LTD.

USA
Heike Schoen

LUMIS International gMBh

Germany
Nigel Rulewski

Quintiles Inc.

USA
Daniel Galbraith

BioOutsource Ltd.

UK
Surendra J Chavan

Quantimmune Solutions Pvt. Ltd.

India
Dieter Tzschoppe

European Patent Office

Germany
Mohan Dewan

R.K. Dewan & Co.

India
James C Shehan

Hyman, Phelps & McNamara

USA
Charu Manaktala

Quintiles Inc.

India
Jennifer Campbell

Merck Millipore

France
Kaiser Jamil

Bhagwan Mahavir Medical Research Centre

India
Harish Shandilya

INTAS Biopharmaceuticals Ltd.

India
J Vijay Venkatraman

Oviya MedSafe

India
Kamlesh Patel

Abbott HealthCare Pvt. Ltd

India
Naveen Kulkarni

Polyclone Bioservices Private Limited

India
Vivek Kashyap

Lex Orbis IP Practice

India
Aparna Kasinath

Clinigene International Limited

India
Conference: Biosimilars-2014, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact: biosimilars2014@omicsonline.net
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Journal of Bioanalysis & Biomedicine, Journal of Bioequivalence & Bioavailability and Journal of Pharmaceutical Sciences & Emerging Drugs
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved